Health Care Archives - Page 450 of 478

1 minute read

Eagle Pharma Broadens Acute Care Portfolio With Equity Stake In Respiratory Depression Player

August 9, 8:51 AM

Eagle Pharmaceuticals Inc (NASDAQ:EGRX) has agreed to make a $25 million equity investment in Enalare Therapeutics Inc. The investment consists of upfront…

EGRX

1 minute read

AstraZeneca’s Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients

By Vandana Singh

August 9, 8:43 AM

AstraZeneca Plc (NASDAQ:AZN) reported initial results from the TROPION-Lung02 phase 1b trial showing that datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab…

AZN

1 minute read

Verona Pharma’s Lung Disease Candidate Cuts COPD Exacerbations By 42%

By Vandana Singh

August 9, 7:39 AM

Verona Pharma plc (NASDAQ:VRNA) has announced topline results from Phase 3 ENHANCE-2 of nebulized ensifentrine for the maintenance treatment of chronic…

VRNA

1 minute read

Analyst Sees This ‘Specialty Pharma’ Stock Stuck Until Prescription Trends Improve

By Vandana Singh

August 8, 2:23 PM

Last week, Collegium Pharmaceutical Inc (NASDAQ:COLL) reported Q2 results—the first full quarter with BioDelivery—and beat revenue and EBITDA estimates. HC Wainwright…

COLL

1 minute read

Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications

By Vandana Singh

August 8, 2:09 PM

Sarepta Therapeutics Inc (NASDAQ:SRPT) will license a new group of adeno-associated viruses from the institute for undisclosed upfront payment and milestone…

SRPT

1 minute read

‘Street Underestimates Jazz Pharma’s Cash-Flow’ Says This Analyst

By Vandana Singh

August 5, 3:16 PM

HC Wainwright tweaked the price target on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) to $204 with a reiterated Buy rating on slightly increased forward…

JAZZ

1 minute read

Pfizer, Global Blood Therapeutics In Advanced Talks For $5B Buyout Deal: Report

By Vandana Singh

August 5, 12:20 PM

Pfizer Inc (NYSE: PFE) is reportedly in advanced talks to buy Global Blood Therapeutics Inc (NASDAQ: GBT) for about $5 billion, bolster its portfolio and pipeline.

GBT

1 minute read

Neurocrine Biosciences Shares Jump After Raising Ingrezza Sales Guidance

By Vandana Singh

August 5, 11:33 AM

Tucked in its Q2 earning release, Neurocrine Biosciences Inc (NASDAQ:NBIX) said that in August, the Phase 2a study of NBI-827104…

NBIX

1 minute read

Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024

By Vandana Singh

August 5, 11:13 AM

Voyager Therapeutics Inc (NASDAQ:VYGR) unveiled its prioritized therapeutic pipeline focusing on tau antibody for Alzheimer’s disease and gene therapies for GBA1…

NVS

1 minute read

Akebia’s Anemia Drug Disappoints In Mid-Stage COVID-19 Study

By Vandana Singh

August 5, 11:12 AM

Akebia Therapeutics Inc (NASDAQ:AKBA) announced initial findings from an investigator-sponsored study evaluating vadadustat for Acute Respiratory Distress Syndrome (ARDS) with COVID-19…

AKBA